Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-03

Clinical Trial Update: Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol [Phase 4]

View source ↗

Summary

This Phase 4 trial compared splitting Vytorin 10/80 into four tablets versus taking Simvastatin 20 mg for lowering LDL cholesterol in people with hypercholester…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simvastatin 20 mg (simvastatin)
  • Vytorin 10/80 (split into 4 tablets) (ezetimibe/simvastatin)

Snippet

Sponsor: Bronx VA Medical Center | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2013-07-03